Vir Biotechnology “announced that Executive Vice President, and Chief Medical Officer, Phil Pang, M.D., Ph.D., has decided to leave the company at the end of March 2024 to spend more time with his family. The Company has initiated a search for a successor.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VIR:
- Biotech Alert: Searches spiking for these stocks today
- Vir Biotechnology price target raised to $110 from $85 at H.C. Wainwright
- Vir Biotechnology downgraded to Neutral from Overweight at JPMorgan
- Vir Biotechnology price target lowered to $85 from $95 at H.C. Wainwright
Questions or Comments about the article? Write to editor@tipranks.com